跳至主要内容
临床试验/NCT04153305
NCT04153305已完成不适用

European Registry for Myeloproliferative Neoplasms (MPNs) - Update of ERNEST Study

FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS6 个研究点 分布在 3 个国家目标入组 1,010 人开始时间: 2019年10月8日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
1,010
试验地点
6
主要终点
Number of death

研究概览

简要总结

The Fondazione per la Ricerca Ospedale di Bergamo (FROM) decided to propose and promote the completion of ERNEST registry: the aim of the project is to obtain up-to-date estimates of clinical outcome of these patients in primary and secondary Myelofibrosis that have been included in the 'original' ERNEST study. The last was conducted between 2012 and beginning of 2015 including 1292 patients with Myelofibrosis, but it was interrupted in 2015 because of bankruptcy of the previous sponsor.

详细描述

Follow-up of patients already been registered in the ERNEST registry resulting alive and/or in active surveillance at November 2014 (Blood 2014 124:1849) will be updated retrospectively until December 2020. Data collection will be centralized at Fondazione per la Ricerca Ospedale di Bergamo (FROM), and performed by a web-based and Electronic Data Capture (EDC) system through ad hoc electronic case report forms (e-CRFs). The e-CRFs system will be pre-filled with pre-existing data collected from cases already entered in the registry. Information on therapies received and outcome events occurred (in term of death, evolution to acute leukemia, secondary cancer and cardiovascular complications) until December 2020 will be recorded by authorized participating investigators.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • previous registration in the ERNEST registry (2012 - 2014)
  • diagnosis of MF performed between January 2001 and 2012 December
  • Signed informed consent to continue participation in the registry

排除标准

  • 未提供

结局指标

主要结局

Number of death

时间窗: 18 years

Overall Survival

次要结局

  • Number of patients with secondary tumor (ST)(18 years)
  • Number of patients with evolution to acute leukemia (AL)(18 years)
  • Number of patients with cardiovascular (CV) complications(18 years)

研究者

发起方
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
申办方类型
Other
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验